Understanding Esketamine (Spravato®): The Nasal Spray for Depression
Imagine you’ve tried two antidepressants, but a heavy fog of depression remains. You’re not alone; this “treatment-resistant” reality of depression affects over 7 million U.S. adults. The pursuit of relief took a dramatic turn in 2019. The FDA approved Esketamine (Spravato®) Nasal Spray, a rapid-acting therapy with a radically different approach. By targeting the brain’s glutamate system, it can start […]
